| 000 | 01151 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516211010.0 | ||
| 264 | 0 | _c20151214 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1873-2496 | ||
| 024 | 7 |
_a10.1016/j.urolonc.2013.10.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFraser, Michael | |
| 245 | 0 | 0 |
_aGenomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer. _h[electronic resource] |
| 260 |
_bUrologic oncology _cFeb 2015 |
||
| 300 |
_a85-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aGenomics _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPrecision Medicine _xmethods |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aProstatic Neoplasms, Castration-Resistant _xgenetics |
| 700 | 1 | _aBerlin, Alejandro | |
| 700 | 1 | _aBristow, Robert G | |
| 700 | 1 | _avan der Kwast, Theodorus | |
| 773 | 0 |
_tUrologic oncology _gvol. 33 _gno. 2 _gp. 85-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2013.10.020 _zAvailable from publisher's website |
| 999 |
_c23771363 _d23771363 |
||